Victory Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Victory Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-43,352	Closed	-$6.62M	–	2886
2019 Q3	$6.62M	Buy	43,352 +10,526	+32%	+$1.72M	0.01%	1102
2019 Q2	$4.23M	Buy	32,826 +8,510	+35%	+$1.01M	0.01%	953
2019 Q1	$2.86M	Sell	24,316 -6,780	-22%	-$684K	0.01%	998
2018 Q4	$2.85M	Buy	31,096 +12,730	+69%	+$1.29M	0.01%	948
2018 Q3	$2.06M	Sell	18,366 -950	-5%	-$100K	﹤0.01%	1092
2018 Q2	$1.78M	Sell	19,316 -1,040	-5%	-$101K	﹤0.01%	1100
2018 Q1	$2.03M	Buy	20,356 +2,060	+11%	+$222K	﹤0.01%	1067
2017 Q4	$1.72M	Buy	+18,296	New	+$1.73M	﹤0.01%	1088

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

Victory Capital Management's LKFT Position: Q4 2019 in Review

Victory Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2019, closing a stake of 43,352 shares — an estimated $6.62M sold.

Victory Capital Management first reported a position in LKFT in Q4 2017 and held it in 8 quarters. The position peaked at $6.62M in Q3 2019. 137 funds tracked by Wall St. Rank hold LKFT as of Q4 2019.

Victory Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2019 after selling out during the quarter.
Victory Capital Management sold 43,352 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2019, an estimated $6.62M.
Victory Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2017 and held it in 8 quarters.
Victory Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $6.62M in Q3 2019.
137 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2019.

Based on Victory Capital Management's 13F filing for Q4 2019, filed 4 Feb 2020.